 Press Release Distribution |
 |
Filter News Show All ResultsNews By Country
News By Tag Pwrm  Related Tags Bc-serapro
Biomedical Biotechnology Cancer CLNO Crwe Dr. Ira L. Goldknopf Helen R. Park Justin Handy Nuropro Orfg Otc:pwrm Otcbb:pwrm Penny To Buck Power 3 Medical Products Power3 Power3 Medical Power3 Medical Products Pwrm Ob Pwrm.ob
| pwrm News+ XML/RSSBy Derrick Bosket GreenHouse estimates that the projects will generate $400,000 in revenue for GRHU By Derrick Bosket Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. By Derrick Bosket American Video has under consideration in the province of Quebec. By Derrick Bosket AIG expects that over time the Treasury Department will sell its stake in AIG subject to market conditions. By Derrick Bosket Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. By Derrick Bosket The acquisition of Rozetta-Cell is expected to be completed in February 2011. By Derrick Bosket Orofino Gold Corp. has several Gold development properties in Colombia, a current hot spot of gold production in the world markets. By Derrick Bosket Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. By Derrick Bosket Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. By Derrick Bosket LXU Q3 2010 net sales were $138.9 million, an 8.7% increase from $127.8 million By Derrick Bosket Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into PWRM, with Power3 remaining as the surviving company. By Derrick Bosket Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with PWRM remaining as the surviving company. By Derrick Bosket Enzo Biochem reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations. By Lynn Lumpkin Enzo Biochem, Inc. (NYSE:ENZ) reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations. By Derrick Bosket PWRM tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a drug, and the mechanisms of disease present in patient for optimal targeted therapy. By Derrick Bosket Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with PWRM remaining as the surviving company. By Derrick Bosket The acquisition of Rozetta-Cell is expected to be completed in February 2011. By Derrick Bosket Orofino Gold Corp. acquired a 55% interest in the Mina Azul/La Estrella property with the rights to acquire up to 80%. By Derrick Bosket Alzheimer’s is not an everyday part of growing older, although the most significant known risk factor is increasing age, and the most of people with Alzheimer’s are 65 and older. By Derrick Bosket Power3 has completed Phase I clinical trials, and NuroPro By Derrick Bosket Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with PWRM remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011. By Derrick Bosket PWRM today announced that company management believes it is making great progress Source CRWESelect : RIVR, PWRM.OB, KEYN, GRHU, AOSL, - River Valley Bancorp, Power3 Medical Products By Derrick Bosket PWRM has filed several patent applications for its NuroPro technology that are currently pending. By Derrick Bosket PWRM has filed several patent applications for its NuroPro technology that are currently pending. By Derrick Bosket About 85 percent of breast cancers begin in the mammary ducts, while about 15 percent arise in the lobules. Tumors in the breast tend to grow slowly. By Derrick Bosket PWRM has filed several patent applications for its NuroPro technology that are currently pending. Source CRWESelect : WIRE, PWRM.OB, ISCA, ORFG.PK, BSFT, - Encore Wire Corp., Power3 Medical Products By Derrick Bosket Breast cancer is a type of cancer by which microscopic cells in the breast separate and develop without normal regulation. By Derrick Bosket PWRM has filed several patent applications for its NuroPro technology that are currently pending. By Derrick Bosket PWRM applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. By Derrick Bosket About 85 percent of breast cancers begin in the mammary ducts, while about 15 percent arise in the lobules. By Derrick Bosket MJS.V’s Song Jiaguo Property is located on the Jiaodong Peninsula in Muping County, the Shandong Province, the People’s Republic of China By Derrick Bosket Breast cancer is a type of cancer tumor where cells within the breast separate and grow without having typical control. By Derrick Bosket PWRM previously signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc. By Derrick Bosket PWRM plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into PWRM, with PWRM remaining as the surviving company in the merger. By Derrick Bosket Majestic Gold Corp. is a Vancouver-based; TSX Venture Exchange and Frankfurt Exchange listed gold exploration and development company with a very advanced gold deposit in Shandong province of China. By Derrick Bosket PWRM has filed several patent applications for its NuroPro technology that are currently pending. By Derrick Bosket The acquisition of Rozetta-Cell is expected to be completed in November 2010. By Derrick Bosket PWRM signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM) a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, By Greg Lumpkin PWRM pursues an aggressive intellectual property strategy to protect its inventions and discoveries made on its own and with its collaborators. By Derrick Bosket The course, named Risk Investor Decision-Making Flow, was instructed by IDGVC Partners (www.idgvc.com/en/ ), a China-focused investment firm with over US$2.5B capital under management. By Derrick Bosket PWRM has filed several patent applications for its NuroPro technology that are currently pending. By Steve Gray Forrester Research, Inc. (NASDAQ:FORR) recently honored 16 Forrester Groundswell Award winners for excellence in effective use of social technologies to advance an organizational or business goal. By Derrick Bosket In addition, PWRM has filed several patent applications for its NuroPro technology that are currently pending. By Derrick Bosket PWRM has filed several patent applications for its NuroPro technology that are currently pending. By Steve Gray Power3 Medical Products, Inc. (OTC.BB:PWRM) announced that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii. By Derrick Bosket Crown Equity Holdings is in the process of developing its Arabic language CRWENewswire site for news occurring in Pakistan and elsewhere around the world. By Blayne Sheffield PWRM.OB, HMA, RDN, & NVE: NV Energy, Inc. Reports Third Quarter Earnings By Blayne Sheffield Power3 has filed several patent applications for its NuroPro® technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. By Derrick Bosket Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. | ||||||||||||||||||||||
Like PRLog?
2.8K1.1K1.1K